Authors:
Marie E. Alutis Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Marie E. Alutis in
Current site
Google Scholar
PubMed
Close
,
Ursula Grundmann Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ursula Grundmann in
Current site
Google Scholar
PubMed
Close
,
Ulrike Hagen Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ulrike Hagen in
Current site
Google Scholar
PubMed
Close
,
André Fischer Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by André Fischer in
Current site
Google Scholar
PubMed
Close
,
Anja A. Kühl Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Anja A. Kühl in
Current site
Google Scholar
PubMed
Close
,
Ulf B. Göbel Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ulf B. Göbel in
Current site
Google Scholar
PubMed
Close
,
Stefan Bereswill Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Stefan Bereswill in
Current site
Google Scholar
PubMed
Close
, and
Markus M. Heimesaat Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Markus M. Heimesaat in
Current site
Google Scholar
PubMed
Close
Open access

Increased levels of the matrix metalloproteinases (MMPs)-2 and -9 (also referred to gelatinase-A and -B, respectively) can be detected in the inflamed gut. We have recently shown that synthetic gelatinase blockage reduces colonic apoptosis and pro-inflammatory immune responses following murine Campylobacter (C.) jejuni infection. In order to dissect whether MMP-2 and/or MMP-9 is involved in mediating C. jejuni-induced immune responses, infant MMP-2-/-, MMP-9-/-, and wildtype (WT) mice were perorally infected with the C. jejuni strain B2 immediately after weaning. Whereas, at day 2 postinfection (p.i.), fecal C. jejuni B2 loads were comparable in mice of either genotype, mice expelled the pathogen from the intestinal tract until day 4 p.i. Six days p.i., colonic MMP-2 but not MMP-9 mRNA was upregulated in WT mice. Remarkably, infected MMP-2-/- mice exhibited less frequent abundance of blood in feces, less distinct colonic histopathology and apoptosis, lower numbers of effector as well as innate and adaptive immune cells within the colonic mucosa, and higher colonic IL-22 mRNA levels as compared to infected WT mice. In conclusion, these results point towards an important role of MMP-2 in mediating C. jejuni-induced intestinal immunopathogenesis.

  • 1.

    Young KT , Davis LM, Dirita VJ: Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5, 665679 (2007)

  • 2.

    Dasti JI , Tareen AM, Lugert R, Zautner AE, Gross U: Campylobacter jejuni: a brief overview on pathogenicityassociated factors and disease-mediating mechanisms. Int J Med Microbiol 300, 205211 (2010)

    • Search Google Scholar
    • Export Citation
  • 3.

    Guerry P , Szymanski CM: Campylobacter sugars sticking out. Trends Microbiol 16, 428435 (2008)

  • 4.

    Lane JA , Mehra RK, Carrington SD, Hickey RM: The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract. Int J Food Microbiol 142, 113 (2010)

    • Search Google Scholar
    • Export Citation
  • 5.

    Kist M , Bereswill S: Campylobacter jejuni. Contrib Microbiol 8, 150165 (2001)

  • 6.

    Wakerley BR , Uncini A, Yuki N, Group GBSC, Group GBSC: Guillain–Barré and Miller Fisher syndromes –new diagnostic classification. Nat Rev Neurol 10, 537544 (2014)

    • Search Google Scholar
    • Export Citation
  • 7.

    van Spreeuwel JP , Duursma GC, Meijer CJ, Bax R, Rosekrans PC, et al.: Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut 26, 945951 (1985)

    • Search Google Scholar
    • Export Citation
  • 8.

    Walker RI , Caldwell MB, Lee EC, Guerry P, Trust TJ, et al.: Pathophysiology of Campylobacter enteritis. Microbiol Rev 50, 8194 (1986)

  • 9.

    Masanta WO , Heimesaat MM, Bereswill S, Tareen AM, Lugert R, et al.: Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol, 526860 (2013)

    • Search Google Scholar
    • Export Citation
  • 10.

    Heimesaat MM , Bereswill S: Murine infection models for the investigation of Campylobacter jejuni–host interactions and pathogenicity. Berl Munch Tierarztl Wochenschr 128, 98103 (2015)

    • Search Google Scholar
    • Export Citation
  • 11.

    Haag LM , Fischer A, Otto B, Grundmann U, Kühl AA, et al.: Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp) 2, 211 (2012)

    • Search Google Scholar
    • Export Citation
  • 12.

    Heimesaat MM , Haag LM, Fischer A, Otto B, Kühl AA, et al.: Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp) 3, 174182 (2013)

    • Search Google Scholar
    • Export Citation
  • 13.

    Birkedal-Hansen H , Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, et al.: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4, 197250 (1993)

    • Search Google Scholar
    • Export Citation
  • 14.

    Goetzl EJ , Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 156, 14 (1996)

  • 15.

    Brinckerhoff CE , Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3, 207214 (2002)

    • Search Google Scholar
    • Export Citation
  • 16.

    Nelson AR , Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18, 11351149 (2000)

    • Search Google Scholar
    • Export Citation
  • 17.

    Crawford HC , Matrisian LM: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 2037 (1996)

    • Search Google Scholar
    • Export Citation
  • 18.

    Saren P , Welgus HG, Kovanen PT: TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157, 41594165 (1996)

    • Search Google Scholar
    • Export Citation
  • 19.

    Salmela MT , MacDonald TT, Black D, Irvine B, Zhuma T, et al.: Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut 51, 540547 (2002)

    • Search Google Scholar
    • Export Citation
  • 20.

    Munoz M , Heimesaat MM, Danker K, Struck D, Lohmann U, et al.: Interleukin (IL)-23 mediates Toxoplasma gondiiinduced immunopathology in the gut via matrixmetalloproteinase- 2 and IL-22 but independent of IL-17. J Exp Med 206, 30473059 (2009)

    • Search Google Scholar
    • Export Citation
  • 21.

    Heimesaat MM , Dunay IR, Fuchs D, Trautmann D, Fischer A, et al.: The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J Microbiol Immunol (Bp) 1, 302310 (2011)

    • Search Google Scholar
    • Export Citation
  • 22.

    Bailey CJ , Hembry RM, Alexander A, Irving MH, Grant ME, et al.: Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn’s disease and normal intestine. J Clin Pathol 47, 113116 (1994)

    • Search Google Scholar
    • Export Citation
  • 23.

    Baugh MD , Perry MJ, Hollander AP, Davies DR, Cross SS, et al.: Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117, 814822 (1999)

    • Search Google Scholar
    • Export Citation
  • 24.

    von Lampe B , Barthel B, Coupland SE, Riecken EO, Rosewicz S: Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47, 6373 (2000)

    • Search Google Scholar
    • Export Citation
  • 25.

    Vanlaere I , Libert C: Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 22, 224239 (2009)

    • Search Google Scholar
    • Export Citation
  • 26.

    Handley SA , Miller VL: General and specific host responses to bacterial infection in Peyer’s patches: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection. Mol Microbiol 64, 94110 (2007)

    • Search Google Scholar
    • Export Citation
  • 27.

    Kundu P , Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, et al.: Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 281, 3465134662 (2006)

    • Search Google Scholar
    • Export Citation
  • 28.

    Bergin PJ , Raghavan S, Svensson H, Starckx S, Van Aelst I, et al.: Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. FEMS Immunol Med Microbiol 52, 8898 (2008)

    • Search Google Scholar
    • Export Citation
  • 29.

    Bodger K , Ahmed S, Pazmany L, Pritchard DM, Micheal A, et al.: Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection. J Clin Pathol 61, 7278 (2008)

    • Search Google Scholar
    • Export Citation
  • 30.

    Takeda M , Imada K, Sato T, Ito A: Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase. Biochem Biophys Res Commun 268, 128132 (2000)

    • Search Google Scholar
    • Export Citation
  • 31.

    Alutis ME , Grundmann U, Fischer A, Kühl AA, Bereswill S, et al.: Selective gelatinase inhibition reduces apoptosis and pro-inflammatory immune cell responses in Campylobacter jejuni-infected gnotobiotic IL-10 deficient mice. Eur J Microbiol Immunol (Bp) 4, 213222 (2014)

    • Search Google Scholar
    • Export Citation
  • 32.

    Bereswill S , Fischer A, Plickert R, Haag LM, Otto B, et al.: Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6, e20953 (2011)

    • Search Google Scholar
    • Export Citation
  • 33.

    Haag LM , Fischer A, Otto B, Plickert R, Kühl AA, et al.: Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. PLoS One 7, e40761 (2012)

    • Search Google Scholar
    • Export Citation
  • 34.

    Heimesaat MM , Lugert R, Fischer A, Alutis M, Kühl AA, et al.: Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice. PLoS One 9, e90148 (2014)

    • Search Google Scholar
    • Export Citation
  • 35.

    Heimesaat MM , Alutis M, Grundmann U, Fischer A, Tegtmeyer N, et al.: The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol 4, 77 (2014)

    • Search Google Scholar
    • Export Citation
  • 36.

    Paclik D , Berndt U, Guzy C, Dankof A, Danese S, et al.: Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl) 86, 13951406 (2008)

    • Search Google Scholar
    • Export Citation
  • 37.

    Heimesaat MM , Nogai A, Bereswill S, Plickert R, Fischer A, et al.: MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59, 10791087 (2010)

    • Search Google Scholar
    • Export Citation
  • 38.

    Bereswill S , Munoz M, Fischer A, Plickert R, Haag LM, et al.: Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5, e15099 (2010)

    • Search Google Scholar
    • Export Citation
  • 39.

    Heimesaat MM , Fischer A, Alutis M, Grundmann U, Boehm M, et al.: The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice. Gut Pathog 6, 16 (2014)

    • Search Google Scholar
    • Export Citation
  • 40.

    Haag LM , Fischer A, Otto B, Plickert R, Kühl AA, et al.: Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 7, e35988 (2012)

    • Search Google Scholar
    • Export Citation
  • 41.

    Eidenschenk C , Rutz S, Liesenfeld O, Ouyang W: Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol 380, 213236 (2014)

  • 42.

    Ouyang WJ , Rutz S, Crellin NK, Valdez PA, Hymowitz SG: Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29, 29, 71109 (2011)

    • Search Google Scholar
    • Export Citation
  • 43.

    Edwards LA , Nistala K, Mills DC, Stephenson HN, Zilbauer M, et al.: Delineation of the innate and adaptive Tcell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 5, e15398 (2010)

    • Search Google Scholar
    • Export Citation
  • 44.

    Malik A , Sharma D, St Charles J, Dybas LA, Mansfield LS: Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunol 7, 802817 (2014)

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita, Prof. Dr. Pharm, Dr. rer. nat., University of Magdeburg, Germany

Editor(s)-in-Chief: Heimesaat, Markus M., Prof. Dr. med., Charité - University Medicine Berlin, Germany

Editorial Board

  • Berit Bangoura, Dr. DVM. PhD,  University of Wyoming, USA
  • Stefan Bereswill, Prof. Dr. rer. nat., Charité - University Medicine Berlin, Germany
  • Dunja Bruder, Prof. Dr. rer. nat., University of Magdeburg, Germany
  • Jan Buer, Prof. Dr. med., University of Duisburg, Germany
  • Edit Buzas, Prof. Dr. med., Semmelweis University, Hungary
  • Renato Damatta, Prof. PhD, UENF, Brazil
  • Maria Deli, MD, PhD, DSc, Biological Research Center, HAS, Hungary
  • Olgica Djurković-Djaković, Prof. Phd, University of Belgrade, Serbia
  • Jean-Dennis Docquier, Prof. Dr. med., University of Siena, Italy
  • Zsuzsanna Fabry, Prof. Phd, University of Washington, USA
  • Ralf Ignatius, Prof. Dr. med., Charité - University Medicine Berlin, Germany
  • Achim Kaasch, Prof. Dr. med., Otto von Guericke University Magdeburg, Germany
  • Oliver Liesenfeld, Prof. Dr. med., Inflammatix, USA
  • Matyas Sandor, Prof. PhD, University of Wisconsin, USA
  • Ulrich Steinhoff, Prof. PhD, University of Marburg, Germany
  • Michal Toborek, Prof. PhD, University of Miami, USA
  • Susanne A. Wolf, PhD, MDC-Berlin, Germany

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI
  • CABELLS Journalytics

 

2023  
Web of Science  
Total Cites
WoS
674
Journal Impact Factor 3.3
Rank by Impact Factor

Q2

Impact Factor
without
Journal Self Cites
3.1
5 Year
Impact Factor
3.2
Scimago  
Scimago
H-index
15
Scimago
Journal Rank
0.601
Scimago Quartile Score Microbiology (medical) (Q2)
Microbiology (Q3)
Immunology and Allergy (Q3)
Immunology (Q3)
Scopus  
Scopus
Cite Score
5.0
Scopus
CIte Score Rank
Microbiology (medical) Q2
Scopus
SNIP
0.832

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Online only
Submission Fee none
Article Processing Charge 900 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2024 0 80 3
Nov 2024 0 46 2
Dec 2024 0 33 2
Jan 2025 0 61 6
Feb 2025 0 88 2
Mar 2025 0 57 2
Apr 2025 0 0 0